Jul 28, 2026 08:22AM
Jul 20, 2026 05:14AM
Jul 13, 2026 03:13AM
Jul 2, 2026 05:04AM
Jun 29, 2026 06:15AM
Jun 4, 2026 07:00AM
Jun 4, 2026 07:00AM Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at SLEEP 2026, Highlighting Breadth of Sleep Medicine Research
May 5, 2026 12:28PM
Mar 24, 2026 08:52AM
Feb 25, 2026 06:55AM
Feb 25, 2026 06:55AM
Feb 12, 2026 07:30AM
Feb 12, 2026 07:30AM
Jan 28, 2026 02:16AM Alkermes (ALKS) PT Raised to $47 at UBS
Dec 5, 2025 04:01PM
Nov 20, 2025 06:40AM
Nov 19, 2025 06:00AM
Nov 19, 2025 06:00AM
Nov 17, 2025 05:52AM
Nov 17, 2025 05:45AM
Nov 14, 2025 07:45AM Alkermes responds to competing offer for Avadel from Lundbeck
Nov 14, 2025 07:45AM
Nov 14, 2025 05:45AM
Nov 14, 2025 05:45AM
Nov 12, 2025 09:57AM
Nov 11, 2025 06:05AM
Nov 5, 2025 09:00AM
Oct 28, 2025 07:00AM Alkermes plc Reports Third Quarter 2025 Financial Results
Oct 27, 2025 06:43AM
Oct 23, 2025 06:42AM
Oct 22, 2025 03:19PM
Oct 22, 2025 02:44PM
Oct 22, 2025 07:00AM
Oct 22, 2025 07:00AM
Dec 14, 2023 06:05AM Alkermes (ALKS) to Sell Athlone, Ireland Facility to Novo Nordisk (NVS)
Dec 14, 2023 06:05AM
Nov 1, 2022 04:01PM
Feb 16, 2022 07:00AM
Oct 27, 2021 07:00AM
Aug 2, 2021 09:31AM
Jul 28, 2021 07:00AM
Apr 28, 2021 07:00AM Alkermes plc Reports First Quarter 2021 Financial Results
Feb 11, 2021 07:00AM
Dec 10, 2020 07:08AM
Dec 10, 2020 07:00AM
Oct 29, 2020 07:00AM
Oct 12, 2020 09:29AM
Jul 29, 2020 07:00AM
Apr 29, 2020 07:00AM Alkermes Plc Reports First Quarter 2020 Financial Results and Provides COVID-19 Related Business Update
Feb 13, 2020 07:00AM

1,178,427 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All